Eva Renee Barnett - 07 Jan 2022 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role
Chief Financial Officer
Signature
/s/ Eva Renee Barnett
Issuer symbol
IMVT
Transactions as of
07 Jan 2022
Net transactions value
-$217,203
Form type
4
Filing time
11 Jan 2022, 09:53:30 UTC
Previous filing
18 Oct 2021
Next filing
19 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMVT Common Stock Sale $217,203 -29,959 -15% $7.25 172,541 07 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 4, 2021, the holder was granted 59,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on October 5, 2021. These RSUs vested in their entirety on January 1, 2022. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of these RSUs.